StockData

Advanced Biomed vs VirnetX

ADVB and VHC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADVB and VHC compare

VirnetX is the larger company, worth 10 times as much as Advanced Biomed ($38.0M against $3.7M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADVBVHC
Size and price
Market cap$3.7M$38.0M
Share price$2.22$9.01
Change, 1 year−75.2%−59.3%
Change, 5 years–−83.3%
Beta (5Y)1.321.27
Employees1213
StockData Score
Total score88
Valuation score2 (better)0
Growth score02 (better)
Performance score11
Health score55
Dividend score00
Valuation
P/E0.4×–
P/S–333×
P/B0.3× (better)2.5×
Growth
Revenue growth (TTM)–128%
Revenue growth, 5Y average–−77.8%
Profitability
Operating margin–−18078%
Net margin–−17374%
Return on equity84.8% (better)−82.1%
Return on invested capital–−1044%
Financial health
Debt / equity0.000.00
Current ratio9.33 (better)6.24
Altman Z-score1.29 (better)−13.58
Piotroski F-score4 (better)3
Dividends and buybacks
Buyback yield−6.8%–
Shareholder yield−6.8%0.00% (better)
Ownership
Held by institutions–13.9%
Held by insiders0.00%17.5%
Insider net buying, 12 months–−$489K
Short interest, % of float0.68%3.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.